Reactions of cisplatin and cis-[PtI

Amino Acids / metabolism Ammonia / metabolism Antineoplastic Agents / chemistry Cisplatin / analogs & derivatives Cytochromes c / metabolism Imidazoles / metabolism Models, Molecular Muramidase / metabolism Organoplatinum Compounds / chemistry Protein Binding Spectrometry, Mass, Electrospray Ionization / methods
Cis-diiodo-diamino‑platinum Cisplatin DFT ESI-MS Ligand substitution Protein sidechain Trans effect

Journal

Journal of inorganic biochemistry
ISSN: 1873-3344
Titre abrégé: J Inorg Biochem
Pays: United States
ID NLM: 7905788

Informations de publication

Date de publication:
08 2020
Historique:
received: 11 02 2020
revised: 17 04 2020
accepted: 26 04 2020
pubmed: 3 6 2020
medline: 26 5 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

Quite surprisingly, cisplatin and cis-[PtI

Identifiants

DOI: 10.1016/j.jinorgbio.2020.111096 PMID: 32485478
pubmed: 32485478
pii: S0162-0134(20)30124-0
doi: 10.1016/j.jinorgbio.2020.111096
pii:
doi:

Substances chimiques

Amino Acids 0
Antineoplastic Agents 0
Imidazoles 0
Organoplatinum Compounds 0
diammine-diiodoplatin 13841-96-8
Ammonia 7664-41-7
imidazole 7GBN705NH1
Cytochromes c 9007-43-6
Muramidase EC 3.2.1.17
Cisplatin Q20Q21Q62J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111096

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Iogann Tolbatov (I)

Dipartimento di Farmacia, Università degli Studi "G. D'Annunzio" Chieti-Pescara, Via dei Vestini, I-66100 Chieti, Italy.

Tiziano Marzo (T)

Department of Pharmacy, University of Pisa, via Bonanno Pisano 6, 56126 Pisa, Italy.

Damiano Cirri (D)

Laboratory of Metals in Medicine (MetMed), Department of Chemistry "U. Schiff", University of Florence, via della Lastruccia 3, 50019, Sesto F.no, Italy; Department of Chemistry and Industrial Chemistry, University of Pisa, via Moruzzi, 13, 56124 Pisa, Italy.

Chiara Gabbiani (C)

Department of Chemistry and Industrial Chemistry, University of Pisa, via Moruzzi, 13, 56124 Pisa, Italy.

Cecilia Coletti (C)

Dipartimento di Farmacia, Università degli Studi "G. D'Annunzio" Chieti-Pescara, Via dei Vestini, I-66100 Chieti, Italy.

Alessandro Marrone (A)

Dipartimento di Farmacia, Università degli Studi "G. D'Annunzio" Chieti-Pescara, Via dei Vestini, I-66100 Chieti, Italy.

Roberto Paciotti (R)

Dipartimento di Farmacia, Università degli Studi "G. D'Annunzio" Chieti-Pescara, Via dei Vestini, I-66100 Chieti, Italy.

Luigi Messori (L)

Laboratory of Metals in Medicine (MetMed), Department of Chemistry "U. Schiff", University of Florence, via della Lastruccia 3, 50019, Sesto F.no, Italy.

Nazzareno Re (N)

Dipartimento di Farmacia, Università degli Studi "G. D'Annunzio" Chieti-Pescara, Via dei Vestini, I-66100 Chieti, Italy. Electronic address: nre@unich.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measures.

Pauline Corbaux, Matthieu Bainaud, Adrien Rousseau et al.
1.00
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged

Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.

Arpine Sokratian, Ye Zhou, Meltem Tatli et al.
1.00
alpha-Synuclein Humans Animals Mice Lewy Body Disease

New emerging treatment options for metastatic melanoma: a systematic review and meta-analysis of skin cancer therapies.

Anan S Jarab, Walid A Al-Qerem, Lina M Khdour et al.
1.00
Humans Melanoma Skin Neoplasms Antineoplastic Combined Chemotherapy Protocols Randomized Controlled Trials as Topic

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'azote › Ammoniac › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Produits chimiques inorganiques › Composés du platine › Cisplatine › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Hémoprotéines › Cytochromes › Cytochromes de type c › Cytochromes c › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles moléculaires › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Glycosidases › Lysozyme › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Composés chimiques organiques › Composés organométalliques › Composés organiques du platine › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Métabolisme › Liaison aux protéines › Reactions of cisplatin and cis-[PtI
questionsmedicales.fr › Techniques d'investigation › Techniques de chimie analytique › Spectrométrie de masse › Spectrométrie de masse ESI › Reactions of cisplatin and cis-[PtI